logo
Breakthrough Minimally Invasive Procedure Cures Rare Thyroid Disorder Without Scars

Breakthrough Minimally Invasive Procedure Cures Rare Thyroid Disorder Without Scars

Hans India23-07-2025
Bengaluru: A 41-year-old woman Sudha (name changed), admitted to Aster Whitefield, underwent a complex and uncommon procedure where a rare form of retrosternal goitre (a thyroid swelling) was successfully treated using a combination of thyroid artery embolization (TAE) and Radiofrequency ablation (RFA). This minimally invasive approach helped the patient to get rid of the swelling that had extended deep into the chest and avoid a risky open surgery, thereby assuring her a speedy recovery.
The patient, a professor at a university, had been having trouble breathing when in a recumbent position, as well as palpable neck swelling. Although retrosternal goiters typically present in elderly individuals, predominantly women over 50, this case was exceptional due to the patient's young age and the remarkable extent of the goiter's growth, reaching as far as the aortic arch. The cause of multinodular goiters in younger women, may arise secondary to iodine deficiency, hereditary goiter syndromes, or prolonged stimulation by thyroid-stimulating hormone (TSH), although we couldn't establish cause in this patient.
The case was handled by interventional radiology team comprising Dr. Dheeraj Shyam, Lead Consultant – Interventional Radiology, and Dr. Madhushree, Specialist – Interventional Radiology, of Aster Whitefield Hospital using a minimally invasive procedure- Thyroid artery embolisation.
A Preliminary CT angiogram and an ultrasound was done. It revealed that the enlarged multinodular thyroid was deriving blood supply from two pairs of thyroid arteries namely inferior and superior thyroid arteries on either sides. In this case the predominant arterial supply of the goitre was from right inferior thyroid artery. The interventional radiology team performed a minimally invasive procedure called thyroid artery embolisation. The procedure significantly reduced the size of the goiter overtime alleviating the patient's symptoms. Real-time imaging was employed, and three out of four arteries were occluded using medically safe particles (PVA particles), effectively cutting off the blood supply thus causing the goiter to shrink. RFA was a reinforcement strategy for one of the small nodule reported as Bethesda III, which again was a minimally invasive method.
'Thyroid artery embolization' is a precise and targeted procedure, beneficial for patients with large multinodular goitre and retrosternal goiters who are either unsuitable for surgery or prefer to avoid it.
In this case, the dominant arterial supply from the right inferior thyroid artery allowed us to safely perform embolisation using polyvinyl alcohol particles. This significantly reduced thyroid vascularity and size. In India, thyroid artery embolization (TAE) and radiofrequency ablation (RFA) for benign thyroid conditions, such as retrosternal goitre, are not yet widely available and remain limited to specialized tertiary care centers, said Dr. Dheeraj Shyam, Lead Consultant – Interventional Radiology at Aster Whitefield Hospital.
Careful planning was essential due to the proximity of the goitre to the aortic arch and mediastinal structures. The use of real-time ultrasound and fluroscopy guidance helped us precisely target the artery and nodule. With embolization and RFA, we achieved optimal volume reduction and symptom relief, while sparing the patient the risks of open neck surgery,' said Dr. Madhushree, Specialist Interventional radiologist, Aster Whitefield Hospital.
The patient responded well, reporting major relief in breathing within days. A follow-up scan after four weeks revealed the thyroid was smaller and less vascular. With no complications and very little stay in hospital, she returned to normal life shortly with few follow-ups scheduled to check on her recovery.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Thalassemics in lurch as LNJP doctor set to retire
Thalassemics in lurch as LNJP doctor set to retire

New Indian Express

time12 hours ago

  • New Indian Express

Thalassemics in lurch as LNJP doctor set to retire

NEW DELHI: Thalassemia patients over 12 years of age at the Lok Nayak Hospital are reportedly worried, as the facility has instructed them to seek an alternative place for treatment. The patients allege that the only doctor from the paediatric Thalassemia ward treating them, is set to retire with no replacement from the hospital in sight. They have written to the facility's Medical Director (MD) requesting the hospital administration to arrange a permanent doctor from the General Medicine department for the care of Thalassemics. Officials said about 63 patients aged over 12 years will be affected by the purported move of the hospital. When reached out for comments, no response was received from LNJP MD Dr BL Chaudhary. 'It is our humble request that we are all Thalassemia patients who have been receiving regular blood transfusions and treatment from Loknayak Hospital since birth. For years, we have received excellent treatment under the supervision of Dr. Sudha (Pediatric Thalassemia Ward), for which we are extremely grateful. We have recently received the information that Dr. Sudha is going to retire in the next few months. This information is a matter of great concern for us, as we are all worried about our regular medical care and future treatment after her,' patients' letter to the hospital's MD read.

Fatty liver reversal with apple cider vinegar? What experts reveal about ACV's effect on your body's largest gland
Fatty liver reversal with apple cider vinegar? What experts reveal about ACV's effect on your body's largest gland

Economic Times

timea day ago

  • Economic Times

Fatty liver reversal with apple cider vinegar? What experts reveal about ACV's effect on your body's largest gland

Synopsis Non-alcoholic fatty liver disease affects a significant portion of the global population, prompting interest in remedies like apple cider vinegar (ACV). While animal studies suggest ACV might reduce liver fat and improve metabolism, human research is limited. Experts recommend ACV as a supplement, not a cure, emphasizing diet, exercise, and medical guidance for managing NAFLD. Fatty liver disease, especially the non-alcoholic kind (NAFLD), is quietly becoming one of the biggest health issues worldwide. According to a TOI report, it affects over 30% of the global population, and in regions like the Americas and Southeast Asia, the figure exceeds 40%. That's worrying. But can something as humble as apple cider vinegar (ACV) help ease the condition? Let's break it Fatty Liver Disease (NAFLD) happens when fat builds up in your liver, without heavy drinking being the cause. It's often linked to being overweight, diabetic, or having a sluggish metabolism. If not managed early, NAFLD can progress to more serious stages like NASH (inflammation), fibrosis, cirrhosis, or even liver cancer. This has led many to turn to home remedies, ACV being one of the most popular. But does it really help your liver?Apple cider vinegar is made by fermenting apple juice into alcohol, and then into acetic acid, the compound responsible for its sharp taste and supposed health often marketed as a metabolism booster, fat burner, and blood sugar regulator. Some claim it can reduce liver fat and support liver function. But what does science actually say? A 2025 study on rainbow trout with NAFLD, as reported by TOI, found that a 2% ACV mix reduced liver fat (steatosis), triglycerides, and key liver enzymes like ALT and AST. But here's the twist, when the dose was doubled to 4%, the condition set of studies on rodents fed high-fat diets showed similar findings. ACV helped reduce liver fat, improve insulin resistance, and lower glucose levels. In one experiment, liver fat levels dropped from 56% to 20%.Researchers believe acetic acid may promote fat-burning and ease metabolic stress. However, all these results come from animal studies, not research is still limited. A 2021 review, quoted by TOI, suggested ACV could lower cholesterol and fasting blood sugar, both helpful for those with NAFLD. But there's no strong proof yet of a direct impact on liver fat in short: promising, but far from perks May support blood sugar and fat metabolism Could assist in weight loss when used with diet and exercise Might improve some metabolic markers over time But here's the catch Too much ACV can damage tooth enamel, cause low potassium, and upset your stomach It may interact badly with diabetes or blood pressure medications Most experts advise no more than 1–2 tablespoons a day, diluted in water Health professionals, as quoted by TOI, warn against treating ACV as a 'cure'. It's a supplement, not a substitute for actual medical treatment or lifestyle changes. Use raw, unfiltered ACV (look for 'the mother') Dilute properly: Mix 1 tablespoon in a full glass of water Drink after meals to avoid acid reflux Rinse your mouth or use a straw to protect your teeth Watch for side effects like bloating or discomfort Talk to your doctor if you're on any medication While ACV may offer some small benefits for metabolism, it's not a cure-all for fatty liver. The best way to reverse NAFLD is through a balanced diet, regular exercise, and guidance from your healthcare provider. Apple cider vinegar might play a supporting role, but it's definitely not the hero of the story. Disclaimer: This article is for informational purposes only and not a substitute for professional medical advice. Always seek the advice of your doctor with any questions about a medical condition.

Elon Musk slams rivals for too many satellites even as SpaceX owns over 60% of those orbiting Earth
Elon Musk slams rivals for too many satellites even as SpaceX owns over 60% of those orbiting Earth

Hindustan Times

time6 days ago

  • Hindustan Times

Elon Musk slams rivals for too many satellites even as SpaceX owns over 60% of those orbiting Earth

Elon Musk and his company SpaceX have launched more than 9,000 satellites into orbit, which means they now control over 60 per cent of all active satellites circling Earth. With plans to send up tens of thousands more for Starlink's global internet project, SpaceX has become the biggest player in the satellite game. The company insists these satellites will deliver high-speed broadband everywhere, from big cities to remote villages. Earth's orbit grows more crowded as major companies battle over satellite launches and the risks of a packed night sky.(AP) But despite this staggering presence, SpaceX has written to the US Federal Communications Commission (FCC) to complain about a competing company, AST SpaceMobile, and its own satellite launches. SpaceX's letter accuses AST of not doing enough to prevent space collisions and of leaving too many risks unaddressed. They claim AST's plans could raise the chances of accidents in orbit, and even bring dangers if a satellite re-enters Earth's atmosphere. According to SpaceX, AST's risk models are not strict enough and their strategies for keeping satellites under control fall short. This protest, coming from a company that holds the lion's share of all satellites, strikes many as ironic. Critics note SpaceX's history of launching massive numbers of devices while warning others about the dangers of a crowded orbit. Alongside worries about collisions, astronomers are also concerned about all this activity. Some SpaceX satellites already shine so brightly after sunset that they stand out in the night sky, and AST's satellites may be even bigger and brighter. Their massive 'BlueBird' satellites are designed to unfurl panels as large as a tennis court, making them visible to the naked eye and raising concerns among skywatchers. Competition in space SpaceX and AST have been locked in arguments for years, especially over technical standards and radio band emission rules. AST has previously accused SpaceX of using 'anticompetitive' tactics with government agencies and other industry players, saying that SpaceX is trying to stifle new entrants and direct attention away from its own technical challenges. Despite the back and forth, the underlying concerns are real. Space is getting more crowded, which raises the chance of collisions, failed satellites, and orbital debris. Both companies have plenty to fix if they want to avoid harming astronomy and keep Earth's orbit safe for everyone. As the commercial space race heats up, big players and new startups are all striving for space and occasionally, calling each other out. The latest spat is just one example of a growing issue: how to keep the skies above us open, safe, and fair in a gold rush for orbital real estate.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store